Page 5 - Nasdaq Blu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq blu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Blu Today - Breaking & Trending Today

-$0.18 Earnings Per Share Expected for BELLUS Health Inc. (NASDAQ:BLU) This Quarter

Equities analysts expect BELLUS Health Inc. (NASDAQ:BLU – Get Rating) to announce earnings of ($0.18) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for BELLUS Health’s earnings, with the lowest EPS estimate coming in at ($0.19) and the highest estimate coming in at ($0.18). BELLUS Health […] ....

Thomson Reuter , Zurcher Kantonalbank Zurich Cantonalbank , Goldman Sachs Group Inc , Zacks Investment Research , Blackrock Inc , Health Inc , Health Get Rating , Walleye Capital , Walleye Trading , Get Rating , Zacks Investment , Investment Research , Kantonalbank Zurich Cantonalbank , Goldman Sachs Group , Bellus Health , Nasdaq Blu ,

BELLUS Health Inc. (NASDAQ:BLU) Receives Consensus Recommendation of "Buy" from Analysts

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) has been given an average recommendation of “Buy” by the six analysts that are currently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued a report on the stock […] ....

Morgan Stanley , Geode Capital Management , Goldman Sachs Group Inc , Zacks Investment Research , Health Inc , Bellus Health Inc , Health Get Rating , Artal Group , Get Rating , Marketbeat Ratings , Investment Research , Sachs Group , Capital Management , Bellus Health , Nasdaq Blu ,

BELLUS Health (NASDAQ:BLU) Sees Large Volume Increase

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) saw strong trading volume on Tuesday . 15,392 shares changed hands during mid-day trading, a decline of 96% from the previous session’s volume of 417,084 shares.The stock last traded at $7.62 and had previously closed at $7.48. Several research firms recently issued reports on BLU. Zacks Investment Research […] ....

Thomson Reuter , Morgan Stanley , Geode Capital Management , Goldman Sachs Group Inc , Zacks Investment Research , Health Inc , Bellus Health Inc , Health Company Profile , Artal Group , Royal Bank , Get Rating , Investment Research , Sachs Group , Capital Management , Company Profile , Bellus Health , Nasdaq Blu ,

Analysts Set BELLUS Health Inc. (NASDAQ:BLU) PT at $14.35

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) has received a consensus rating of “Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have updated their coverage on the stock in the last […] ....

Morgan Stanley , Goldman Sachs Group Inc , Virtu Financial , Zacks Investment Research , Health Inc , Bellus Health Inc , Health Company Profile Get Rating , Citadel Advisors , Millennium Management , Royal Bank , Get Rating , Investment Research , Sachs Group , Company Profile , Bellus Health , Nasdaq Blu ,